These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse. Spirito F; Charlesworth A; Linder K; Ortonne JP; Baird J; Meneguzzi G J Invest Dermatol; 2002 Sep; 119(3):684-91. PubMed ID: 12230513 [TBL] [Abstract][Full Text] [Related]
4. Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy. Spirito F; Capt A; Del Rio M; Larcher F; Guaguere E; Danos O; Meneguzzi G Biochem Biophys Res Commun; 2006 Jan; 339(3):769-78. PubMed ID: 16316622 [TBL] [Abstract][Full Text] [Related]
5. A missense mutation (G1506E) in the adhesion G domain of laminin-5 causes mild junctional epidermolysis bullosa. Scaturro M; Posteraro P; Mastrogiacomo A; Zaccaria ML; De Luca N; Mazzanti C; Zambruno G; Castiglia D Biochem Biophys Res Commun; 2003 Sep; 309(1):96-103. PubMed ID: 12943669 [TBL] [Abstract][Full Text] [Related]
6. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Kivirikko S; McGrath JA; Baudoin C; Aberdam D; Ciatti S; Dunnill MG; McMillan JR; Eady RA; Ortonne JP; Meneguzzi G Hum Mol Genet; 1995 May; 4(5):959-62. PubMed ID: 7633458 [TBL] [Abstract][Full Text] [Related]
7. Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa. De Rosa L; Secone Seconetti A; De Santis G; Pellacani G; Hirsch T; Rothoeft T; Teig N; Pellegrini G; Bauer JW; De Luca M Cell Rep; 2019 May; 27(7):2036-2049.e6. PubMed ID: 31091444 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Pulkkinen L; Christiano AM; Airenne T; Haakana H; Tryggvason K; Uitto J Nat Genet; 1994 Mar; 6(3):293-7. PubMed ID: 8012393 [TBL] [Abstract][Full Text] [Related]
9. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa. Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767 [TBL] [Abstract][Full Text] [Related]
10. Cloning of the laminin alpha 3 chain gene (LAMA3) and identification of a homozygous deletion in a patient with Herlitz junctional epidermolysis bullosa. Vidal F; Baudoin C; Miquel C; Galliano MF; Christiano AM; Uitto J; Ortonne JP; Meneguzzi G Genomics; 1995 Nov; 30(2):273-80. PubMed ID: 8586427 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of the human laminin alpha3a chain gene (LAMA3a): a strategy for mutation identification and DNA-based prenatal diagnosis in Herlitz junctional epidermolysis bullosa. Pulkkinen L; Cserhalmi-Friedman PB; Tang M; Ryan MC; Uitto J; Christiano AM Lab Invest; 1998 Sep; 78(9):1067-76. PubMed ID: 9759651 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta. Nakamura H; Sawamura D; Goto M; Nakamura H; Kida M; Ariga T; Sakiyama Y; Tomizawa K; Mitsui H; Tamaki K; Shimizu H Int J Mol Med; 2006 Aug; 18(2):333-7. PubMed ID: 16820943 [TBL] [Abstract][Full Text] [Related]
13. Detection of novel LAMA3 mutation in Herlitz junctional epidermolysis bullosa in a Jordanian family. Badran EF; Battah HA; Akl KF; Khalil RW; Al Amori I Australas J Dermatol; 2013 Aug; 54(3):218-21. PubMed ID: 22963541 [TBL] [Abstract][Full Text] [Related]
14. Gentamicin induces Lincoln V; Cogan J; Hou Y; Hirsch M; Hao M; Alexeev V; De Luca M; De Rosa L; Bauer JW; Woodley DT; Chen M Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6536-E6545. PubMed ID: 29946029 [TBL] [Abstract][Full Text] [Related]
15. Novel mutations in the LAMC2 gene in non-Herlitz junctional epidermolysis bullosa: effects on laminin-5 assembly, secretion, and deposition. Castiglia D; Posteraro P; Spirito F; Pinola M; Angelo C; Puddu P; Meneguzzi G; Zambruno G J Invest Dermatol; 2001 Sep; 117(3):731-9. PubMed ID: 11564184 [TBL] [Abstract][Full Text] [Related]
16. Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging. Gache Y; Allegra M; Bodemer C; Pisani-Spadafora A; de Prost Y; Ortonne JP; Meneguzzi G Hum Mol Genet; 2001 Oct; 10(21):2453-61. PubMed ID: 11689492 [TBL] [Abstract][Full Text] [Related]
17. Lack of K140 immunoreactivity in junctional epidermolysis bullosa skin and keratinocytes associates with misfolded laminin epidermal growth factor-like motif 2 of the β3 short arm. Condorelli AG; Fortugno P; Cianfarani F; Proto V; Di Zenzo G; Didona B; Zambruno G; Castiglia D Br J Dermatol; 2018 Jun; 178(6):1416-1422. PubMed ID: 28561256 [TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient. Benati D; Miselli F; Cocchiarella F; Patrizi C; Carretero M; Baldassarri S; Ammendola V; Has C; Colloca S; Del Rio M; Larcher F; Recchia A Mol Ther; 2018 Nov; 26(11):2592-2603. PubMed ID: 30122422 [TBL] [Abstract][Full Text] [Related]
19. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in Herlitz junctional epidermolysis bullosa: prenatal exclusion in a fetus at risk. McGrath JA; Kivirikko S; Ciatti S; Moss C; Dunnill GS; Eady RA; Rodeck CH; Christiano AM; Uitto J Genomics; 1995 Sep; 29(1):282-4. PubMed ID: 8530087 [TBL] [Abstract][Full Text] [Related]
20. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations. McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]